 | • レポートコード：GIR201114927 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、早期陣痛治療の世界市場を調査対象にし、早期陣痛治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（プロゲステロン、OBE-022、レトシバン、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：AMAG Pharmaceuticals Inc、Kissei Pharmaceutical Co Ltd、GlaxoSmithKline Plc、Juniper Pharmaceuticals Inc、ObsEva SA、Lipocine Inc ・企業別売上、市場シェア ・早期陣痛治療の地域別市場分析 ・早期陣痛治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・早期陣痛治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・早期陣痛治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・早期陣痛治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・早期陣痛治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・早期陣痛治療の種類別市場規模2015-2020：プロゲステロン、OBE-022、レトシバン、その他 ・早期陣痛治療の用途別市場規模2015-2020：病院、クリニック、その他 ・早期陣痛治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Premature Labor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Premature Labor Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Premature Labor Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Premature Labor Treatment market has been segmented into:
Progesterone
OBE-022
Retosiban
Others
By Application, Premature Labor Treatment has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Premature Labor Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Premature Labor Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Premature Labor Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Premature Labor Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Premature Labor Treatment Market Share Analysis
Premature Labor Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Premature Labor Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Premature Labor Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Premature Labor Treatment are:
AMAG Pharmaceuticals Inc
Kissei Pharmaceutical Co Ltd
GlaxoSmithKline Plc
Juniper Pharmaceuticals Inc
ObsEva SA
Lipocine Inc
Table of Contents
1 Premature Labor Treatment Market Overview
1.1 Product Overview and Scope of Premature Labor Treatment
1.2 Classification of Premature Labor Treatment by Type
1.2.1 Global Premature Labor Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Premature Labor Treatment Revenue Market Share by Type in 2019
1.2.3 Progesterone
1.2.4 OBE-022
1.2.5 Retosiban
1.2.6 Others
1.3 Global Premature Labor Treatment Market by Application
1.3.1 Overview: Global Premature Labor Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Premature Labor Treatment Market by Regions
1.4.1 Global Premature Labor Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Premature Labor Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Premature Labor Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Premature Labor Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Premature Labor Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Premature Labor Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Premature Labor Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 AMAG Pharmaceuticals Inc
2.1.1 AMAG Pharmaceuticals Inc Details
2.1.2 AMAG Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AMAG Pharmaceuticals Inc SWOT Analysis
2.1.4 AMAG Pharmaceuticals Inc Product and Services
2.1.5 AMAG Pharmaceuticals Inc Premature Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kissei Pharmaceutical Co Ltd
2.2.1 Kissei Pharmaceutical Co Ltd Details
2.2.2 Kissei Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kissei Pharmaceutical Co Ltd SWOT Analysis
2.2.4 Kissei Pharmaceutical Co Ltd Product and Services
2.2.5 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline Plc SWOT Analysis
2.3.4 GlaxoSmithKline Plc Product and Services
2.3.5 GlaxoSmithKline Plc Premature Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Juniper Pharmaceuticals Inc
2.4.1 Juniper Pharmaceuticals Inc Details
2.4.2 Juniper Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Juniper Pharmaceuticals Inc SWOT Analysis
2.4.4 Juniper Pharmaceuticals Inc Product and Services
2.4.5 Juniper Pharmaceuticals Inc Premature Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 ObsEva SA
2.5.1 ObsEva SA Details
2.5.2 ObsEva SA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ObsEva SA SWOT Analysis
2.5.4 ObsEva SA Product and Services
2.5.5 ObsEva SA Premature Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Lipocine Inc
2.6.1 Lipocine Inc Details
2.6.2 Lipocine Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Lipocine Inc SWOT Analysis
2.6.4 Lipocine Inc Product and Services
2.6.5 Lipocine Inc Premature Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Premature Labor Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Premature Labor Treatment Players Market Share
3.2.2 Top 10 Premature Labor Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Premature Labor Treatment Revenue and Market Share by Regions
4.2 North America Premature Labor Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Premature Labor Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Premature Labor Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Premature Labor Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Premature Labor Treatment Revenue and Growth Rate (2015-2020)
5 North America Premature Labor Treatment Revenue by Countries
5.1 North America Premature Labor Treatment Revenue by Countries (2015-2020)
5.2 USA Premature Labor Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Premature Labor Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Premature Labor Treatment Revenue and Growth Rate (2015-2020)
6 Europe Premature Labor Treatment Revenue by Countries
6.1 Europe Premature Labor Treatment Revenue by Countries (2015-2020)
6.2 Germany Premature Labor Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Premature Labor Treatment Revenue and Growth Rate (2015-2020)
6.4 France Premature Labor Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Premature Labor Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Premature Labor Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Premature Labor Treatment Revenue by Countries
7.1 Asia-Pacific Premature Labor Treatment Revenue by Countries (2015-2020)
7.2 China Premature Labor Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Premature Labor Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Premature Labor Treatment Revenue and Growth Rate (2015-2020)
7.5 India Premature Labor Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Premature Labor Treatment Revenue and Growth Rate (2015-2020)
8 South America Premature Labor Treatment Revenue by Countries
8.1 South America Premature Labor Treatment Revenue by Countries (2015-2020)
8.2 Brazil Premature Labor Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Premature Labor Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Premature Labor Treatment by Countries
9.1 Middle East & Africa Premature Labor Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Premature Labor Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Premature Labor Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Premature Labor Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Premature Labor Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Premature Labor Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Premature Labor Treatment Market Forecast by Type (2019-2024)
10.3 Progesterone Revenue Growth Rate (2015-2025)
10.4 OBE-022 Revenue Growth Rate (2015-2025)
10.5 Retosiban Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Premature Labor Treatment Market Segment by Application
11.1 Global Premature Labor Treatment Revenue Market Share by Application (2015-2020)
11.2 Premature Labor Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Premature Labor Treatment Market Size Forecast (2021-2025)
12.1 Global Premature Labor Treatment Market Size Forecast (2021-2025)
12.2 Global Premature Labor Treatment Market Forecast by Regions (2021-2025)
12.3 North America Premature Labor Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Premature Labor Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Premature Labor Treatment Revenue Market Forecast (2021-2025)
12.6 South America Premature Labor Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Premature Labor Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Premature Labor Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Premature Labor Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Premature Labor Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Premature Labor Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AMAG Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 6. AMAG Pharmaceuticals Inc Premature Labor Treatment Major Business
Table 7. AMAG Pharmaceuticals Inc Premature Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 8. AMAG Pharmaceuticals Inc SWOT Analysis
Table 9. AMAG Pharmaceuticals Inc Premature Labor Treatment Product and Solutions
Table 10. AMAG Pharmaceuticals Inc Premature Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Kissei Pharmaceutical Co Ltd Corporate Information, Location and Competitors
Table 12. Kissei Pharmaceutical Co Ltd Premature Labor Treatment Major Business
Table 13. Kissei Pharmaceutical Co Ltd Premature Labor Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Kissei Pharmaceutical Co Ltd SWOT Analysis
Table 15. Kissei Pharmaceutical Co Ltd Premature Labor Treatment Product and Solutions
Table 16. Kissei Pharmaceutical Co Ltd Premature Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GlaxoSmithKline Plc Corporate Information, Location and Competitors
Table 18. GlaxoSmithKline Plc Premature Labor Treatment Major Business
Table 19. GlaxoSmithKline Plc Premature Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 20. GlaxoSmithKline Plc SWOT Analysis
Table 21. GlaxoSmithKline Plc Premature Labor Treatment Product and Solutions
Table 22. GlaxoSmithKline Plc Premature Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Juniper Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 24. Juniper Pharmaceuticals Inc Premature Labor Treatment Major Business
Table 25. Juniper Pharmaceuticals Inc Premature Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Juniper Pharmaceuticals Inc SWOT Analysis
Table 27. Juniper Pharmaceuticals Inc Premature Labor Treatment Product and Solutions
Table 28. Juniper Pharmaceuticals Inc Premature Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. ObsEva SA Corporate Information, Location and Competitors
Table 30. ObsEva SA Premature Labor Treatment Major Business
Table 31. ObsEva SA Premature Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 32. ObsEva SA SWOT Analysis
Table 33. ObsEva SA Premature Labor Treatment Product and Solutions
Table 34. ObsEva SA Premature Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Lipocine Inc Corporate Information, Location and Competitors
Table 36. Lipocine Inc Premature Labor Treatment Major Business
Table 37. Lipocine Inc Premature Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Lipocine Inc SWOT Analysis
Table 39. Lipocine Inc Premature Labor Treatment Product and Solutions
Table 40. Lipocine Inc Premature Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Premature Labor Treatment Revenue (Million USD) by Players (2015-2020)
Table 42. Global Premature Labor Treatment Revenue Share by Players (2015-2020)
Table 43. Global Premature Labor Treatment Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Premature Labor Treatment Revenue Market Share by Regions (2015-2020)
Table 45. North America Premature Labor Treatment Revenue by Countries (2015-2020)
Table 46. North America Premature Labor Treatment Revenue Market Share by Countries (2015-2020)
Table 47. Europe Premature Labor Treatment Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Premature Labor Treatment Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Premature Labor Treatment Revenue by Countries (2015-2020)
Table 50. South America Premature Labor Treatment Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Premature Labor Treatment Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Premature Labor Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Global Premature Labor Treatment Revenue (Million USD) by Type (2015-2020)
Table 54. Global Premature Labor Treatment Revenue Share by Type (2015-2020)
Table 55. Global Premature Labor Treatment Revenue Forecast by Type (2021-2025)
Table 56. Global Premature Labor Treatment Revenue by Application (2015-2020)
Table 57. Global Premature Labor Treatment Revenue Share by Application (2015-2020)
Table 58. Global Premature Labor Treatment Revenue Forecast by Application (2021-2025)
Table 59. Global Premature Labor Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Premature Labor Treatment Picture
Figure 2. Global Premature Labor Treatment Revenue Market Share by Type in 2019
Figure 3. Progesterone Picture
Figure 4. OBE-022 Picture
Figure 5. Retosiban Picture
Figure 6. Others Picture
Figure 7. Premature Labor Treatment Revenue Market Share by Application in 2019
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Premature Labor Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Premature Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Premature Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Premature Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Premature Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Premature Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Premature Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Premature Labor Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Premature Labor Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Premature Labor Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Premature Labor Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Premature Labor Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Premature Labor Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Premature Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Premature Labor Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Premature Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Premature Labor Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Premature Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Premature Labor Treatment Revenue Market Share by Countries in 2019
Figure 44. China Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Premature Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Premature Labor Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Premature Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Premature Labor Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Premature Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Premature Labor Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Premature Labor Treatment Revenue Share by Type in 2019
Figure 61. Global Premature Labor Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Progesterone Revenue Growth Rate (2015-2020)
Figure 63. Global OBE-022 Revenue Growth Rate (2015-2020)
Figure 64. Global Retosiban Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Premature Labor Treatment Revenue Share by Application (2015-2020)
Figure 67. Global Premature Labor Treatment Revenue Share by Application in 2019
Figure 68. Global Premature Labor Treatment Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Revenue Growth Rate (2015-2020)
Figure 70. Global Clinic Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Premature Labor Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Premature Labor Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Premature Labor Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Premature Labor Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Premature Labor Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Premature Labor Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Premature Labor Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Premature Labor Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
早漏治療の世界市場 2020年 Market Overview The global Premature Ejaculation Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 1936.8 million by 2025, from USD 1492.2 million in 2019. The Prem…- 早産・膜早期破裂（PROM）検査の世界市場 2020年 Market Overview The global Preterm Birth and Premature Rupture of Membranes (PROM) Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mi…
- 個人用労働保護具の世界市場 2020年 Market Overview The Personal Labor Protective Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 軟骨無形成症治療の世界市場 2020年 Market Overview The global Achondroplasia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Achondroplasia Treat…
- 不安障害及びうつ病治療の世界市場 2020年 Market Overview The Anxiety Disorder and Depression Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…